Patents by Inventor Noa Avisar

Noa Avisar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant Human Albumin-Human Granulocyte Colony Stimulating Factor for the Prevention of Neutropenia in Pediatric Patients
    Publication number: 20140271538
    Abstract: Disclosed are methods and compositions for treating, preventing and ameliorating conditions and diseases characterized by a lowered white blood cell count, including neutropenia, in human patients that are less than 18 years old. The methods and compositions described herein include a fusion polypeptide comprising human serum albumin protein (“HSA”) and human granulocyte-colony stimulating factor (“G-CSF”).
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Anton BUCHNER, Andreas Lammerich, Noa Avisar